LEADER 01400nam  2200313z- 450 
001 9910689677603321
005 20161209103208.0
035   $a(CKB)5860000000018410
035   $a(BIP)008856052
035   $a(EXLCZ)995860000000018410
100   $a20220406c2003uuuu  -u-         -
101 0 $aeng
200 10$aBenefits of integrated drug demand-reduction strategy $eeffects of treatment funding on public health and public safety in Baltimore :  hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, second session, March 5, 2002
215   $a1 online resource (iii, 94 p.) $cill
311   $a0-16-070303-4 
517   $aBenefits of integrated drug demand-reduction strategy 
606   $aDrug abuse$xTreatment$zMaryland$zBaltimore
606   $aDrug abuse$zMaryland$zBaltimore$xPrevention
610   $aDrug abuse
610   $aMaryland
610   $aPsychology
610   $aSocial science
615  0$aDrug abuse$xTreatment
615  0$aDrug abuse$xPrevention.
712 02$aUnited States, Congress House Committee on Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources Staff,$4oth
906   $aBOOK
912   $a9910689677603321
996   $aBenefits of integrated drug demand-reduction strategy$93101907
997   $aUNINA